A Phase 2 Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis
Status:
Not yet recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess efficacy, safety, and pharmacokinetics (PK) of QLM3003
Ointment in participants with mild or moderate atopic dermatitis.